Rockefeller Capital Management L.P.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1739439
NEW YORK, NY
Position in NBIX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$37,163,457
-$2,736,156 QoQ
Shares Held
282,097
+0.3% QoQ
Ownership
0.281%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 69.48071053573771.ToString("F0")%
Shared 0.ToString("F0")%
None 30.519289464262293.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Rockefeller Capital Management L.P. holds $133,569,034 across 49 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (27.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
5,103,509 | $51,086,123 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
282,097 | $37,163,457 | |
| 3 | ZTS |
Zoetis Inc.
|
253,206 | $29,931,479 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
173,438 | $8,351,039 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
64,920 | $1,553,534 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,562 | $926,232 | |
| 7 | VTRS |
Viatris Inc
|
59,826 | $808,247 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
47,612 | $659,425 |
All Filings in NBIX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,163,457 | 282,097 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $39,899,613 | 281,320 | Shares | Defined | 2026-03-17 | |
| 2025-09-30 | $27,226,418 | 193,948 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $14,231,751 | 113,229 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,388,849 | 21,599 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,712,254 | 19,870 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,226,165 | 19,321 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,653,864 | 19,277 | Shares | Defined | 2024-08-12 | |
| 2023-06-30 | $654,913 | 6,945 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $680,804 | 6,726 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $838,587 | 7,021 | Shares | Defined | 2023-03-06 | |
| 2022-09-30 | $751,966 | 7,080 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $704,682 | 7,229 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,175,811 | 12,542 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,085,149 | 12,741 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,054,486 | 21,421 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $60,408,566 | 620,721 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $60,576,732 | 622,897 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $58,170,597 | 606,892 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $32,036,664 | 333,160 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $40,613,922 | 332,901 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $27,029,044 | 312,294 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||